Cardiff Oncology, Inc.
CRDF· Nasdaq
CRDFCardiff Oncology, Inc.
Filed Mar 17, 2014 · 10-K · 76 days after period end · 0001104659-14-020261
| Metric | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $47.00K | $163.00K | $33.75K |
| Net Income | -$1.03M | -$6.33M | -$1.25M |
| EPS Diluted | -$0.05 | -$0.43 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 17, 2014 · 76 d after period end
